Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Par's Pimecrolimus Cream vs Elidel in Atopic Dermatitis
NCT03297502Phase 3Completed
- Sponsor
- Par Pharmaceutical
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD), sponsored by Par Pharmaceutical. Started Jun 2016; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03297502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03297502.